603590 Beijing Konruns Pharmaceutical
- 23.63
- +0.23+0.98%
Beijing Konruns Pharmaceutical News
Kangchen Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks
Notice on Cancelling the Company\'s Repurchase of Shares in Special Securities Accounts
Announcement on repurchase and cancellation of some restricted stocks to which incentives have been granted but sales restrictions have not yet been lifted, and adjustment of repurchase prices
Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted shares
Legal Opinion of Beijing Guofeng Law Firm on Beijing Kangchen Pharmaceutical Co., Ltd.\'s 2023 Restricted Stock Incentive Plan Reserve Grant and First Grant of Part 1 of the First Release Period to Lift Sales Restriction Conditions and Repurchase Cancellation Matters
Announcement on the Company\'s 2023 Restricted Stock Incentive Plan for the first time granting the first sales restriction period to lift sales restrictions and listing
Kangchen Pharmaceutical Announces Results of the 2023 Restricted Stock Incentive Plan Reservation Grant
Kangchen Pharmaceutical\'s progress announcement on changes in the nature of shares and the reservation grant of restricted stock incentive plans
Beijing Konruns Pharmaceutical's Supervisory Board's statement on the publicity and verification of the reserved list of incentive objects for the restricted stock incentive plan for the company in 2023.
Beijing Konruns Pharmaceutical's announcement about the first release of the restricted stock incentive plan in 2023 and the achievement of the first unlocking condition
Announcement of Konruns Pharmaceutical regarding repurchasing restricted stocks that have been granted but have not yet been released from restriction, and adjusting buyback price.
The supervisory board's verification opinion on matters related to the 2023 restricted stock incentive plan.
List of incentive recipients reserved for the Beijing Konruns Pharmaceutical restricted stock incentive plan in 2023.
Legal Opinion of Beijing Guofeng Law Firm on the Restricted Stock Incentive Plan Reserved and Initially Granted, the Achievement of the First Release Period and the Matters of Repurchase and Cancellation of Beijing Konruns Pharmaceutical Co., Ltd.'s Restricted Stock in 2023.
Announcement of Beijing Konruns Pharmaceutical on granting reserved restricted stocks and adjusting the grant price to the restricted stock incentive plan for 2023.
Beijing Konruns Pharmaceutical's Notice on the First Phase Employee Stock Ownership Plan.
Beijing Konruns Pharmaceutical Announcement of Implementation of Annual Equity Distribution in 2023
Kangchen Pharmaceutical's 2023 Annual Profit Distribution Plan Announcement
Kangchen Pharmaceutical's announcement on the freezing of some of the company's shareholders' shares
Kangchen Pharmaceutical announced the results of the first grant of the 2023 Restricted Stock Incentive Plan
Analysis
Price Target
No Data
No Data